ScholarWorks@Korea University College of Medicine: Son, Sang Wook

Detailed Information

Son, Sang Wook (손상욱)

Ansan Hospital (Department of Dermatology, Ansan Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Atopic dermatitis:8||Keratinocyte:6||psoriasis:5||Egr1:5||Microarray:5||Phototoxicity:4||Psoriasis:4||Guideline:4||Cytotoxicity:4||atopic dermatitis:4||STAT3:4||Skin sensitization:4||Dermatitis:3||Keratinocytes:3||Human skin equivalent model:3||mitogenactivated protein kinase:3||Early growth response1:3||Skin irritation:3||ZnO:3||Reactive oxygen species:3||cigarette smoke:2||Gene expression profiling:2||Basal cell carcinoma:2||Toluene:2||IL33:2||AKT:2||Administration:2||Imiquimod:2||Treatment:2||ERK:2||nanoparticles:2||nanomaterials:2||Skin:2||Gene expression:2||Nanoparticles:2||epigenetic:2||rice bran supercritical CO2 extract:2||Skin barrier:2||alopecia:2||cDNA microarray:2||silica nanoparticles:2||Contact dermatitis:2||Recurrence rate:2||Chloroform:2||stereoimage optical topometer:2||Volatile organic compound:2||Volatile organic compounds (VOCs):2||Consensus:2||Skin penetration:2||hair growthpromoting activity:2||Keratoacanthoma:2||Quantum dots:2||toluene:2||Dermoscopy:2||Xylene:2||Antioxidant defense:2||Mohs micrographic surgery:2||atopic:2||ROS:2||Methylation:2||Surveys and questionnaires:2||keratinocyte:2||Awareness:2||Alopecia areata:2||Therapeutics:2||clinical study:2||Dermatologist:1||Diagnosis:1||Diffuse plane xanthoma:1||Disseminated coccidioidomycosis:1||Docetaxel:1||Doseresponse relationship:1||EARLYONSET:1||ECM breakdown:1||EGR1:1||Early growth response protein 1:1||Eczema:1||Endoplasmic reticulum (ER) stress:1||Environmental Risk Assessment:1||Epidermis:1||Er : YAG laser resurfacing:1||Erythema ab igne:1||Ethylbenzene:1||Ethylbenzene (EB):1||Etiology:1||Excision:1||Extracellular signalregulated kinase:1||Extradigital:1||Extramammary Paget's disease:1||FLG:1||Fas:1||Favre Racouchot syndrome:1||Feetbathing:1||Filler:1||Floxed:1||Foreign body granuloma:1||GMCSF:1||Gastric mucosa:1||Giant keratoacanthoma:1||Glomus tumor:1||Griseofulvin:1||H. pylori:1||HAIR LOSS:1||HIF1:1||HSEM:1||Hand eczema:1||Healthrelated quality of life:1||Heterotopia:1||Hollow gold nanosphere:1||Homogeneous sensing probe:1||Human keratinocytes:1||Human papilloma virus:1||Human skin equivalent:1||Human skin fibroblasts:1||Human tail:1||Hydrofluoric acid:1||Hydrogel:1||Hypertension:1||Hypoxiainducible factor1 alpha:1||IL17:1||IL17A:1||INSULINRESISTANCE:1||IQ (R) Chamber:1||Imoquimod 5% cream:1||Interdigitating dendritic cell sarcoma:1||Interferonalpha2a:1||Irritation:1||Iso and Kikuchi syndrome:1||Isotopic response:1||KLK5:1||Kaempferol tetrasaccharide:1||Keloid scar:1||Knockout mouse:1||Knowledge:1||Korea:1||Korea red ginseng:1||Korean:1||Korean red ginseng:1||Korean standard series:1||Laser treatment:1||Lasers:1||Leukemia cutis:1||Lipliner tattoo:1||Lipoma:1||Localized cutaneous leishmaniasis:1||Lymph node metastasis:1||MALEPATTERN BALDNESS:1||MAPK:1||MEN:1||MMP3:1||MYOCARDIALINFARCTION:1||Macrophages:1||Maintenance therapy:1||Melanoma:1||Methorexate:1||Mohs microscopic surgery:1||Mohs surgery:1||Mometasone furoate:1||Monoclonal gammopathy of unknown significance (MGUS):1||Monocytes:1||Multicenter study:1||Multiple dermatofibromas:1||Mycobacterium abscessus:1||NFKB signaling:1||NFkB:1||NK activating receptors:1||NK inhibitory receptors:1||NKG2A:1||NOD2:1||Nail change:1||Nanomaterial:1||Nanoparticle:1||Nanoscale zinc oxide:1||Nanosilica:1||Nanotoxicity:1||Natural extracts:1||Nevus flammeus:1||Nodular fasciitis:1||Nonmelanoma skin cancer:1||Normolipoproteinemia:1||Oral acute toxicity test:1||PASI:1||PCR Array:1||PCR array:1||PDK1:1||PLC gamma 1:1||PREVALENCE:1||Panax ginseng:1||Particulate matter (PM):1||Patch test:1||Phototherapy:1||Pigmentation:1||Plasma cell cheilitis:1||Polystyrene:1||Portwine stain:1||Prognosis:1||Prurigo:1||Pruritus:1||Pseudolymphoma:1||PubMed:1||Public perception:1||Pulsed dye laser:1||Punch biopsy:1||Pyoderma gangrenosum:1||Quality of life:1||Quantum dot:1||Questionnaire:1||RAW 264.7 cells:1||RIP4:1||Ras signaling:1||Rat:1||Recurrent:1||Republic of Korea:1||Restylane®:1||Retinoic acid:1||Rice bran supercritical CO2 extract (RBSCE):1||Risk:1||Rosacea:1||SPINK5:1||Sarcoma:1||Seborrheic dermatitis:1||Secondary intention:1||Segmentation:1||Semipermanent tattoo:1||Serum IgE:1||SiO2 nanoparticles:1||Side effect:1||Signal transducer and activator of transcription 3:1||Silica:1||Silver nanoparticles:1||Skin aging:1||Skin atrophy:1||Skin barrier function:1||Skin fibroblast:1||Skin health:1||Skin lesions:1||Skin neoplasms:1||Stratum corneum:1||Subclinical infiltration:1||Sunlight:1||Superficial basal cell carcinoma:1||Surfaceenhanced Raman scattering:1||Survey:1||Systemic lupus erythematosus:1||Systemic sclerosis:1||Systemic steroid:1||Systemic treatment:1||TNF alpha:1||TREM1:1||TRUE Test (R):1||TRUE test:1||Tacrolimus:1||Tacrolimus ointment:1||Tape stripping method:1||Thalidomide:1||Therapeutics:1||Thymic stromal lymphopoietin:1||TiO2:1||Timedependent exposure:1||Tolllike receptor:1||Topical 0.03% tacrolimus oint:1||Topical administration:1||Toxicity:1||Transepidermal water loss (TEWL):1||Treatment failure:1||Tumor of follicular infundibulum:1||Type II TGFbeta receptor:1||Ultraviolet B:1||Ultraviolet therapy:1||Umbilicus:1||Urban particulate matter:1||Ustekinumab:1||VECTOR (R) NovaRED (TM):1||Vaginal adenosis:1||Vascular endothelial growth factor:1||Vulva cancer:1||Warts:1||Website:1||Wound healing:1||Xanthelasma palpebrarum:1||Zinc Oxide:1||Zinc oxide nanoparticle:1||ZnO nanoparticles:1||ZnONPs:1||acne:1||apoptosis:1||area:1||atopic eczema:1||autologous fat injection:1||autoregulation:1||basal cell carcinoma:1||bioengineering methods:1||bradykinin:1||calcium channels:1||candidiasis:1||clinical trial:1||combination therapy:1||combined exposure:1||comparative analysis:1||concordance:1||consumer characteristics:1||consumers:1||cutaneous infection:1||cysteinerich 61:1||dermal exposure:1||dermal route:1||dermatomycoses:1||digital image analysis:1||drug:1||dystrophic calcification:1||early growth response protein 1:1||early growth response1:1||epidemiology:1||epidermal cystlip:1||ethylbenzene:1||excimer:1||excimer laser:1||experts:1||exposure time:1||face:1||fungi:1||gene expression:1||global assessment scale:1||gold nanorods:1||homeostasis:1||household income:1||human skin equivalent model:1||hyperpigmentation:1||hypopigmentation:1||image analysis:1||immunohistochemistry:1||in vivo:1||interleukin33:1||intravital imaging:1||keratinocytes:1||korean red ginseng:1||long noncoding RNA:1||longterm depression:1||loxP:1||mTOR:1||melanoacanthoma:1||mesenchymal stem cells:1||methylation:1||microangiography:1||microarray:1||moxifloxacin:1||mycoses:1||natural killer cells:1||neurodegenerative diseases:1||no observed adverse effect level:1||noncoding RNA:1||observational study:1||opportunistic infections:1||oral:1||p2 (Waf1/Cip1):1||particle size:1||patch test:1||phase contrast Xray microscope:1||polyelectrolytes:1||prevention:1||protein corona:1||protein kinase C:1||proteintyrosine kinases:1||proteintyrosine phosphatases:1||psoriasin:1||quantum dot:1||quantum dots:1||questionnaire survey:1||registry:1||repigmentation percentage:1||safety:1||seborrheic keratosis:1||severity psoriasis:1||skin ageing:1||skin barrier:1||skin penetration:1||subchronic toxicity:1||surface charge:1||survey:1||synapse:1||synchrotron:1||tamoxifen:1||thymic stromal lymphopoietin:1||topical:1||toxicity:1||treatment:1||treatment outcome:1||tumor necrosis factor alpha:1||ustekinumab:1||visual scoring system:1||vitiligo:1||xylene:1||zebrafish:1||zinc oxide:1||참진드기 교상:1||1:1||포매법:1||1 alpha,25dihydroxyviamin D3:1||3D EpiDerm™ model (EPI200):1||90day oral dose toxicity:1||AD:1||Absorption:1||Acral lentiginous melanoma:1||Acral persistent papular mucinosis:1||Adalimumab:1||Amikacin:1||Anthralin:1||Anxiety:1||Apoptosis:1||Asian population:1||Atypical fibroxanthoma:1||BMP6:1||Beau's line:1||Bee sting:1||Behavior:1||Bichloroacetic acid:1||Bioengineering methods:1||Biomarker:1||Blau syndrome:1||Body regions:1||Bone invasion:1||CARDIOVASCULAR RISKFACTORS:1||CCL20:1||CD34:1||CD94:1||COMMUNITYBASED SURVEY:1||CORONARYHEARTDISEASE:1||Calcium gluconate:1||Cancer drugs:1||Cancer marker:1||Capillary malformation:1||Cell proliferation:1||Cellular imaging:1||Cellular state:1||Chemoimmunotherapy:1||Childhood:1||Chronic hand eczema:1||Cigarette smoking:1||Claudin 1:1||Clear cell syringoma:1||Clinical feature:1||ClueGO:1||Congenital onychodysplasia of the index fingers:1||Congenital smooth muscle hamartoma:1||Consensus guidelines:1||Corneometer:1||Corticosteroid:1||Cre:1||Cryolipolysis:1||Cryotherapy:1||Cutaneous:1||Cutaneous candidiasis:1||Cutaneous horn:1||Cutaneous plasmacytoma:1||Cyclosporine:1||Cysteinerich 61:1||Cytokines:1||DNA methylation profiling:1||Database:1||Depression:1||Dermatofibroma:1||Dermatofibrosarcoma protuberans:1||

STATISTICS: Total View :13,970,393; Today View :18,286

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE